These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21264070)

  • 1. Telomere biology in cardiovascular disease - role of insulin sensitivity in diabetic hearts.
    Makino N; Sasaki M; Maeda T; Mimori K
    Exp Clin Cardiol; 2010; 15(4):e128-33. PubMed ID: 21264070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving insulin sensitivity via activation of PPAR-gamma increases telomerase activity in the heart of OLETF rats.
    Makino N; Maeda T; Oyama J; Higuchi Y; Mimori K
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2188-95. PubMed ID: 19855065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calorie restriction increases telomerase activity, enhances autophagy, and improves diastolic dysfunction in diabetic rat hearts.
    Makino N; Oyama J; Maeda T; Koyanagi M; Higuchi Y; Tsuchida K
    Mol Cell Biochem; 2015 May; 403(1-2):1-11. PubMed ID: 25662949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Yu Y; Ohmori K; Chen Y; Sato C; Kiyomoto H; Shinomiya K; Takeuchi H; Mizushige K; Kohno M
    J Am Coll Cardiol; 2004 Aug; 44(4):904-13. PubMed ID: 15312879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
    Ishida K; Mizuno A; Sano T; Noma Y; Shima K
    Horm Metab Res; 1995 Sep; 27(9):398-402. PubMed ID: 8557237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.
    Hosomi N; Noma T; Ohyama H; Takahashi T; Kohno M
    Atherosclerosis; 2002 May; 162(1):69-76. PubMed ID: 11947899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain.
    Toide K; Man ZW; Asahi Y; Sato T; Nakayama N; Noma Y; Oka Y; Shima K
    Diabetes Res Clin Pract; 1997 Dec; 38(3):151-60. PubMed ID: 9483380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats.
    Yagi K; Kim S; Wanibuchi H; Yamashita T; Yamamura Y; Iwao H
    Hypertension; 1997 Mar; 29(3):728-35. PubMed ID: 9052888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulin-resistant rat.
    Taniguchi Y; Ooie T; Takahashi N; Shinohara T; Nakagawa M; Yonemochi H; Hara M; Yoshimatsu H; Saikawa T
    Diabetes; 2006 Aug; 55(8):2371-8. PubMed ID: 16873703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of aquaporin 7 in perirenal adipose tissue of Otsuka Long-Evans Tokushima Fatty diabetic rats].
    Duan Ym; Yuan Zf; Yao J; Zhang Tt; Chen C; Guo Xh
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 43(1):117-22. PubMed ID: 21321634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rosiglitazone on inflammation in Otsuka long-evans Tokushima Fatty rats.
    Lee JW; Nam-Goong IS; Kim JG; Yun CH; Kim SJ; Choi JI; Kim YI; Kim ES
    Korean Diabetes J; 2010 Jun; 34(3):191-9. PubMed ID: 20617080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
    Taniguchi Y; Takahashi N; Fukui A; Nagano-Torigoe Y; Thuc LC; Teshima Y; Shinohara T; Wakisaka O; Ooie T; Murozono Y; Yufu K; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
    Cardiovasc Res; 2011 Dec; 92(3):439-48. PubMed ID: 21952935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats.
    Jia D; Yamamoto M; Otani M; Otsuki M
    Metabolism; 2004 Apr; 53(4):405-13. PubMed ID: 15045684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram reduces elevated blood glucose levels in Otsuka Long-Evans Tokushima Fatty (OLETF) rats, a model of type 2 diabetes.
    Nagai N; Murao T; Okamoto N; Ito Y
    J Oleo Sci; 2009; 58(9):485-90. PubMed ID: 19654459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
    Park SY; Choi YH; Lee W
    J Ethnopharmacol; 2008 Feb; 115(3):473-82. PubMed ID: 18068920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of a peroxisome proliferator-activated receptor-gamma agonist and an angiotensin II receptor blocker attenuates myocardial fibrosis and dysfunction in type 2 diabetic rats.
    Shim CY; Song BW; Cha MJ; Hwang KC; Park S; Hong GR; Kang SM; Lee JE; Ha JW; Chung N
    J Diabetes Investig; 2014 Jul; 5(4):362-71. PubMed ID: 25411595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone prevents fatty changes of the liver in obese diabetic rats.
    Jia DM; Tabaru A; Akiyama T; Abe S; Otsuki M
    J Gastroenterol Hepatol; 2000 Oct; 15(10):1183-91. PubMed ID: 11106100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.